FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely to neurodegenerative disease, such as Parkinson's disease. The method consists that with underlying drug therapy, cerebrum structure of the patient is exposed to the travelling magnetic field. Duration of each procedure is 15 minutes, and the two first procedures involve 30% of maximum intensity of the magnetic field. Herewith low frequency 10 Hz is applied, and therapeutic course takes 15 days.
EFFECT: application of the invention allows improving clinical effectiveness for Parkinson's disease with favourable effect on anxious depression symptomatology; besides the method has a positive effect on the patient's cognitive function.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PARKINSON'S DISEASE | 2008 |
|
RU2375084C1 |
| METHOD OF MEDICAL REHABILITATION AFTER CEREBRAL STROKE | 2008 |
|
RU2371213C1 |
| METHOD OF TREATING PATIENTS WITH CORONARY HEART DISEASE WITH PSYCHOEMOTIONAL DISORDERS AFTER CORONARY BYPASS SURGERY AT STAGE OF EARLY REHABILITATION USING INFRARED TERAHERTZ RADIATION | 2023 |
|
RU2814504C1 |
| METHOD FOR RECOVERING LOCOMOTOR FUNCTION OF UPPER EXTREMITY ON SIDE OF MASTECTOMY PERFORMED FOR BREAST CANCER | 2019 |
|
RU2700536C1 |
| METHOD FOR INDIVIDUAL CLINICAL AND PSYCHOLOGICAL REHABILITATION OF PATIENTS WITH POST-COVID SYNDROME | 2022 |
|
RU2783330C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC INSOMNIA | 2019 |
|
RU2714296C1 |
| METHOD FOR TREATING MENOPAUSAL SYNDROME WITH COMBINATION OF XENON THERAPY AND GENERAL CRYOTHERAPY | 2023 |
|
RU2804583C1 |
| METHOD FOR TREATING ALOPECIAS WITH CONCOMITANT PSYCHOSOMATIC DISORDERS | 2020 |
|
RU2756002C1 |
| METHOD FOR CORRECTION OF PSYCHOEMOTIONAL AND COGNITIVE DISORDERS BY BIOLOGICAL FEEDBACK IN PATIENTS WITH EARLY CEREBRAL MICROANGIOPATHY | 2023 |
|
RU2819166C1 |
| METHOD FOR CORRECTING COGNITIVE IMPAIRMENT IN PATIENTS DURING THE PERIOD OF CONVALESCENCE OF CORONAVIRUS INFECTION CASED BY THE SARS-CoV-2 VIRUS | 2022 |
|
RU2801379C1 |
